Yanhui Yu
Changzhi, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Author Correction: PD-1 signalling defines and protects leukaemic stem cells from T cell receptor-induced cell death in T cell acute lymphoblastic leukaemia.
Journal: Nature cell biology
Published: August 19, 2025
Author Correction: SHP-1 inhibition targets leukaemia stem cells to restore immunosurveillance and enhance chemosensitivity by metabolic reprogramming.
Journal: Nature cell biology
Published: August 11, 2025
Endoplasmic reticulum stress-related signature predicts prognosis and immune infiltration analysis in acute myeloid leukemia.
Journal: Hematology (Amsterdam, Netherlands)
Published: August 17, 2023
Meta‑analysis of the efficacy of venetoclax and azacitidine combination therapy and azacitidine monotherapy for treating acute myeloid leukemia.
Journal: Experimental and therapeutic medicine
Published: July 25, 2023
SHP-1 inhibition targets leukaemia stem cells to restore immunosurveillance and enhance chemosensitivity by metabolic reprogramming.
Journal: Nature cell biology
Published: March 22, 2023
A Ferroptosis-Inducing and Leukemic Cell-Targeting Drug Nanocarrier Formed by Redox-Responsive Cysteine Polymer for Acute Myeloid Leukemia Therapy.
Journal: ACS nano
Published: February 08, 2023
Fatty acid metabolism predicts prognosis and NK cell immunosurveillance of acute myeloid leukemia patients.
Journal: Frontiers in oncology
Published: August 12, 2022
PD-1 signalling defines and protects leukaemic stem cells from T cell receptor-induced cell death in T cell acute lymphoblastic leukaemia.
Journal: Nature cell biology
Published: January 15, 2022
Showing 1-8 of 8
Last Updated: 09/26/2026